Kiniksa Pharmaceuticals International (KNSA) Metrics: History & Chart

Kiniksa Pharmaceuticals International, plc(KNSA)

Medical - Pharmaceuticals · London, GL

$73.93-2.38 (-3.12%)

Delayed quote: Oct 6, 2026, 10:45 AM EDT

About Kiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.

London, GL

366 employees

www.kiniksa.com

Healthcare / Medical - Pharmaceuticals

Sector: Healthcare
Industry: Medical - Pharmaceuticals
CEO: Sanj K. Patel

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+0.28%
30D Total Return	-2.05%
YTD Total Return	+84.99%
1Y Total Return	+98.26%
3Y Total Return	+366.75%
5Y Total Return	+597.51%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+84.99%
2025	+108.54%
2024	+12.77%
2023	+17.09%
2022	+27.27%
2021	-33.39%
2020

CAGR TTM	+97.61%
CAGR 3Y	+67.10%
CAGR 5Y	+47.48%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	77.87
PE Ratio Avg TTM	76.29
PE Ratio Avg 3Y	93.46
Current VS TTM Avg	+2.07%
Current VS 3Y Avg	-16.68%
Current VS 5Y Avg	+31.45%

All Metrics

KNSA Valuation Metrics

KNSA Stock Price Metrics

KNSA Dividend Metrics

KNSA Growth Rate Metrics

KNSA Discounted Cash Flow Metrics

KNSA Returns By Period

KNSA Yearly Returns

KNSA Average Annual Returns By Period (CAGR)

KNSA Revenue Metrics

KNSA PE Ratio Metrics

KNSA PS Ratio Metrics

KNSA PB Ratio Metrics

KNSA Price to Free Cash Flow Ratio Metrics

KNSA Debt to Equity Ratio Metrics

KNSA PEG Ratio Metrics

KNSA FCF Yield

KNSA Earnings Yield

KNSA EBITDA Yield

KNSA OCF Yield

KNSA EV/EBIT Ratio Metrics

KNSA EV/EBITDA Ratio Metrics

KNSA EV/Assets Ratio Metrics

KNSA EV/Sales Ratio Metrics

KNSA Current Ratio Metrics

KNSA Quick Ratio Metrics

KNSA ROIC Metrics

KNSA Return on Assets Metrics

KNSA Return on Equity Metrics

KNSA Net Profit Margin Metrics

KNSA Gross Profit Margin Metrics

KNSA Tax Rate Metrics

PS Ratio	7.57
PS Ratio Avg TTM	6.09
PS Ratio Avg 3Y	4.93
Current VS TTM Avg	+24.37%
Current VS 3Y Avg	+53.56%
Current VS 5Y Avg	+37.01%

PB Ratio	9.73
PB Ratio Avg TTM	7.30
PB Ratio Avg 3Y	4.92
Current VS TTM Avg	+33.33%
Current VS 3Y Avg	+97.57%
Current VS 5Y Avg	+137.47%

PFCF Ratio	34.76
PFCF Ratio Avg TTM	31.15
PFCF Ratio Avg 3Y	46.87
Current VS TTM Avg	+11.61%
Current VS 3Y Avg	-25.84%
Current VS 5Y Avg	-21.93%

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.02
Debt/Equity Ratio Avg 3Y	0.02
Current VS TTM Avg	-18.18%
Current VS 3Y Avg	-40.79%
Current VS 5Y Avg	-42.67%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	2.88%
FCF Yield Avg TTM	3.21%
FCF Yield Avg 3Y	2.24%
Current VS TTM Avg	-10.37%
Current VS 3Y Avg	+28.70%
Current VS 5Y Avg	+23.82%

Earnings Yield	1.28%
Earnings Yield Avg TTM	1.36%
Earnings Yield Avg 3Y	0.99%
Current VS TTM Avg	-5.86%
Current VS 3Y Avg	+28.69%
Current VS 5Y Avg	-82.99%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	61.82
Ev/Ebit Ratio Avg TTM	62.09
Ev/Ebit Ratio Avg 3Y	59.23
Current VS TTM Avg	-0.43%
Current VS 3Y Avg	+4.38%
Current VS 5Y Avg	+12.14%

Ev/Ebitda Ratio	60.73
Ev/Ebitda Ratio Avg TTM	60.42
Ev/Ebitda Ratio Avg 3Y	57.47
Current VS TTM Avg	+0.51%
Current VS 3Y Avg	+5.67%
Current VS 5Y Avg	+20.84%

Ev/Assets Ratio	6.92
Ev/Assets Ratio Avg TTM	5.18
Ev/Assets Ratio Avg 3Y	3.50
Current VS TTM Avg	+33.54%
Current VS 3Y Avg	+97.54%
Current VS 5Y Avg	+140.16%

Ev/Sales Ratio	7.37
Ev/Sales Ratio Avg TTM	5.84
Ev/Sales Ratio Avg 3Y	4.62
Current VS TTM Avg	+26.25%
Current VS 3Y Avg	+59.65%
Current VS 5Y Avg	+44.78%

Current Ratio	3.90
Current Ratio Avg TTM	3.78
Current Ratio Avg 3Y	3.83
Current VS TTM Avg	+3.29%
Current VS 3Y Avg	+1.82%
Current VS 5Y Avg	-3.86%

Quick Ratio	3.49
Quick Ratio Avg TTM	3.38
Quick Ratio Avg 3Y	3.54
Current VS TTM Avg	+3.38%
Current VS 3Y Avg	-1.54%
Current VS 5Y Avg	-8.09%

ROIC	9.76%
ROIC Avg 3Y	0.04%
ROIC Avg 5Y	0.01%
Current VS 3Y Avg	+24609.44%
Current VS 5Y Avg	+64996.11%
Current VS 10Y Avg	+132.05%

ROA	9.00%
ROA Avg TTM	2.54%
ROA Avg 3Y	0.86%
Current VS TTM Avg	+253.77%
Current VS 3Y Avg	+942.88%
Current VS 5Y Avg	+802.38%

ROE	12.33%
ROE Avg TTM	8.49%
ROE Avg 3Y	2.34%
Current VS TTM Avg	+45.18%
Current VS 3Y Avg	+427.64%
Current VS 5Y Avg	+145.96%

Net Profit Margin	9.59%
Net Profit Margin Avg TTM	9.91%
Net Profit Margin Avg 3Y	3.23%
Current VS TTM Avg	-3.28%
Current VS 3Y Avg	+196.94%
Current VS 5Y Avg	+226.79%

Gross Profit Margin	54.49%
Gross Pft Margin Avg TTM	54.52%
Gross Pft Margin Avg 3Y	57.42%
Current VS TTM Avg	-0.06%
Current VS 3Y Avg	-5.10%
Current VS 5Y Avg	-12.03%

Tax Rate	18.34%
Tax Rate Avg 3Y	(59.12%)
Tax Rate Avg 5Y	(81.77%)
Current VS 3Y Avg	+131.03%
Current VS 5Y Avg	+122.43%
Current VS 10Y Avg	+122.43%